US Patent

US11511252 — Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)

Formulation · Assigned to Vero Biotech Inc · Expires 2029-09-21 · 3y remaining

Vulnerability score 56/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a nitric oxide delivery system that converts nitrogen dioxide to nitric oxide using a surface-active material.

USPTO Abstract

A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal.

Drugs covered by this patent

Patent Metadata

Patent number
US11511252
Jurisdiction
US
Classification
Formulation
Expires
2029-09-21
Drug substance claim
No
Drug product claim
Yes
Assignee
Vero Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.